Serum-Free PDGF Medium for DS Cell Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for culturing dermal sheath (DS) cells rely on serum-containing media, which poses risks of antigenic variation and pathogenic contamination, making them unsuitable for clinical applications, and there is a lack of a serum-free medium containing platelet-derived growth factor (PDGF) specifically designed for DS cell culture.

Innovation Solution

A serum-free medium comprising platelet-derived growth factor (PDGF), particularly PDGF-BB, is used for culturing DS cells, enabling efficient growth and expansion of these cells, suitable for clinical applications and drug development.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If serum-containing medium is used for culturing DS cells, then cell growth and binding to culture vessel are promoted, but antigenic variation and pathogenic contamination risks increase

Engineering Contradiction:
Improvecell growthVSAvoidcontamination risk
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention extracts and removes serum components from the culture medium, replacing them with defined growth factors. This eliminates the harmful elements (antigens, pathogens, unidentifiable trace components) while retaining the essential growth-promoting functions through specifically added factors like PDGF, EGF, and FGF.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the chemical composition parameters of the culture medium by defining exact concentrations of growth factors (PDGF 0.1-10 ng/ml, EGF 0.1-10 ng/ml, FGF 0.1-10 ng/ml) and eliminating serum variables. This creates a controlled, reproducible environment that maintains cell growth while ensuring safety and consistency.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If serum-containing medium is used for culturing DS cells, then cell growth is promoted, but experimental result variability increases

Engineering Contradiction:
Improvecell growthVSAvoidexperimental result consistency
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention defines precise parameter ranges for growth factors (PDGF 0.1-10 ng/ml, EGF 0.1-10 ng/ml, FGF 0.1-10 ng/ml) and other medium components, eliminating the variability inherent in serum batches. This ensures reproducible experimental results across different cultures and laboratories.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a standardized, replicable medium formulation that can be consistently reproduced. The defined composition serves as a template that can be copied across experiments, eliminating the uniqueness and variability of serum-based formulations.

Inventive Principle:
Principle #26Copying

3Reliability

If serum-free medium without PDGF is used for culturing DS cells, then contamination risk is reduced, but cell growth efficiency decreases

Engineering Contradiction:
Improvecontamination riskVSAvoidcell growth efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention introduces platelet-derived growth factor (PDGF) as an intermediary substance that mediates cell growth in the absence of serum. PDGF, along with EGF and FGF, acts as a substitute growth signal that promotes DS cell proliferation without the harmful effects of serum, bridging the gap between safety and efficacy.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite culture medium formulation combining multiple defined growth factors (PDGF, EGF, FGF) at specific concentrations. This composite approach replaces the complex serum mixture with a tailored combination of purified factors that collectively promote cell growth while maintaining the serum-free, contamination-free environment.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS11427807B2Serum-free medium containing PDGF for DS cells
Publication Date: 2022.08.30 SHISEIDO CO LTD
  • US11427807B2 patent drawing
  • US11427807B2 patent drawing
  • US11427807B2 patent drawing

AI summary

The present disclosure relates to a serum-free medium for culturing of DS cells containing platelet derived growth factor (PDGF), or to a method for culturing of dermal sheath (DS) cells, using serum-free medium comprising PDGF.